Zentalis Pharmaceuticals Inc (ZNTL)
11.27
-0.01
(-0.09%)
USD |
NASDAQ |
May 24, 16:00
11.28
+0.01
(+0.09%)
After-Hours: 20:00
Zentalis Pharmaceuticals Accounts Payable (Quarterly): 10.50M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 10.50M |
| December 31, 2023 | 14.93M |
| September 30, 2023 | 14.26M |
| June 30, 2023 | 12.30M |
| March 31, 2023 | 12.82M |
| December 31, 2022 | 11.25M |
| September 30, 2022 | 9.82M |
| June 30, 2022 | 12.04M |
| March 31, 2022 | 13.16M |
| Date | Value |
|---|---|
| December 31, 2021 | 11.59M |
| September 30, 2021 | 8.046M |
| June 30, 2021 | 8.273M |
| March 31, 2021 | 8.337M |
| December 31, 2020 | 8.661M |
| September 30, 2020 | 5.437M |
| June 30, 2020 | 4.217M |
| March 31, 2020 | 7.019M |
| December 31, 2019 | 4.289M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
4.217M
Minimum
Jun 2020
14.93M
Maximum
Dec 2023
9.831M
Average
10.16M
Median
Accounts Payable (Quarterly) Benchmarks
| Revolution Medicines Inc | 32.38M |
| Day One Biopharmaceuticals Inc | 4.78M |
| Perspective Therapeutics Inc | 6.027M |
| Electromed Inc | 0.792M |
| Xtant Medical Holdings Inc | 7.378M |